References
- Arnett F. C., Edsworthy S. M., Bloch D. A., McShane D. J., Fries J. F., Cooper N. S., et al. The American Rheumatism Association 1987. Revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315–324
- Arvidsson N. G., Gudbjörnsson B., Larsson A., Hällgren R. The timing of glucocorticoid administration in rheumatoid arthritis. Ann Rheum Dis 1997; 56: 27–31
- Barland P., Lipstein E. Selection and use of laboratory tests in the rheumatic diseases. Am J Med 1996; 100(2A)16S–23S
- Benderly M., Graff E., Reicher-Reiss H., Behar S., Brunner D., Goldbourt U. Fibrinogen is a predictor of mortality in coronary heart disease patients. Arteriosclerosis Thromb Vasc Biol 1996; 16: 351–356
- Bolibar I., Kienast J., Thompson S. G., Matthias R., Niessner H., Fechtrup C. Relation of fibrinogen to presence and severity of coronary artery disease is independent of other coexisting heart disease. The ECAT Angina Pectoris Study Group. Am. Heart J 1993; 125: 1601–1605
- Davis M. J., Dawes P. T., Fowler P. D., Sheeran T. P., Shadforth M. F., Ziade F., Collins M., Jones P. Comparison and evaluation of a disease activity index for use in patients with rheumatoid arthritis. Br J Rheumatol 1990; 29: 111–115
- Di Minno G., Mancini M. Measuring plasma fibrinogen to predict stroke and myocardial infarction. Arteriosclerosis 1990; 10: 1–7
- Dinant G. J., de Kock C. A., van Wersch J. W. Diagnostic value of C-reactive protein meausrement does not justify replacement of the erythrocyte sedimentation rate in daily general practice. Eur J Clin Invest 1995; 25: 353–359
- Fåhreus R. The suspension-stability of the blood. Acta Med Scand 1921; 55: 1–228
- International Committe for Standardization in Haematology. ICSH recommendations for measurement of erythrocyte sedimentation rate. J Clin Pathol 1993; 46: 198–203
- Kushner I. The phonomenon of the acute phase response. Ann N Y Acad Sci. 1982; 389: 39–48
- Levenson J., Giral P., Razavian M., Gariepy J., Simon A. Fibrinogen and silent atherosclerosis in subjects with cardiovascular risk factors. Arteriosclerosis, Thromb Vasc Biol 1995; 15: 1263–1268
- Mendall M. A., Patel P., Ballam L., Strachan D., Northfield T. C. C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. BMJ 1996; 312: 1061–1065
- Morley J. J., Kushner I. Serum C-reactive protein levels in disease. Ann N Y Acad Sci. 1982; 389: 406–418
- Patel P., Carrington D., Strachan D. P., Leatham E., Goggin P., Northfield T. C., Mendall M. A. Fibrinogen: a link between chronic infection and coronary heart disease ‘letter’. Lancet 1994; 343: 16345
- Ridker P. M., Cushman M., Stampfer M. J., Tracy R. P., Hennekens C. H. Inflammation, aspirin, and the risk of cardiovascular disease in appparently healthy men. New Engl J Med 1997; 336: 973–979
- Ritchie D. M., Boyle J. A., McInnes J. M., Jasani M. K., Dalakas T. G., Grieverson P., et al. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med 1968; 37: 393–406
- Sox H. C., Liang M. H. The erythrocyte sedimentation rate. Guidelines for rational use. Annals Intern Med 1986; 104: 515–523
- Sweetnam P. M., Thomas H. F., Yarnell J. W. G., Beswick A. D., Baker I. A., Elwood P. C. Fibrinogen, viscosity and the 10-year incidence of ischaemic heart disease. Eur Heart J 1996; 17: 1814–1820
- Thompson P. W., Silman A. J., Kirwan J. R., Currey H. L. F. Articular indices of joint inflammation in rheumatoid arthritis. Arthritis Rheum 1987; 30: 1333–1338
- Thompson S. G., Fechtrup C., Squire E., Heyse U., Breithardt G., van de Loo J. W. C., Kienast J. Antithrombin III and fibrinogen as predictors of cardiac events in patients with angina pectoris. Arteriosclerosis Thromb Vasc Biol 1996; 16: 357–362
- Tillet W. S., Francis T. Serological reactions with pneumonia with a non-protein somatic fraction of pneumococcus. J Exp Med 1930; 52: 561–571